EP 0942748 A1 19990922 - ENV-GLYCOPROTEIN VACCINE FOR PROTECTION OF HTLV-I AND -II INFECTION
Title (en)
ENV-GLYCOPROTEIN VACCINE FOR PROTECTION OF HTLV-I AND -II INFECTION
Title (de)
ENV-GLYKOPROTEIN VAKZIN ZUM SCHUTZ VOR HTLV-I UND HTLV-II INFEKTIONEN
Title (fr)
VACCIN A BASE DE GLYCOPROTEINE D'ENVELOPPE DESTINE A PROTEGER CONTRE L'INFECTION A HTLV-I ET HTLV-II
Publication
Application
Priority
- US 9712776 W 19970722
- US 68105496 A 19960722
- US 89789897 A 19970721
Abstract (en)
[origin: WO9803197A1] The present invention relates to novel protein antigens derived from the HTLV env protein, that are capable of being used as a vaccine to aid in the prevention and treatment of HTLV-I and HTLV-II infections and novel methods for the production of such an antigen.
IPC 1-7
IPC 8 full level
A61K 39/21 (2006.01); A61P 25/00 (2006.01); A61P 31/12 (2006.01); C07K 14/16 (2006.01); A61K 39/00 (2006.01)
CPC (source: EP)
A61P 25/00 (2018.01); A61P 31/12 (2018.01); C07K 14/005 (2013.01); A61K 39/00 (2013.01); C12N 2740/16122 (2013.01)
Designated contracting state (EPC)
AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 9803197 A1 19980129; CA 2262007 A1 19980129; EP 0942748 A1 19990922; EP 0942748 A4 20041208; JP 2002513381 A 20020508
DOCDB simple family (application)
US 9712776 W 19970722; CA 2262007 A 19970722; EP 97935044 A 19970722; JP 50717598 A 19970722